JPH02288835A - 抗コクシジウム剤 - Google Patents
抗コクシジウム剤Info
- Publication number
- JPH02288835A JPH02288835A JP10287690A JP10287690A JPH02288835A JP H02288835 A JPH02288835 A JP H02288835A JP 10287690 A JP10287690 A JP 10287690A JP 10287690 A JP10287690 A JP 10287690A JP H02288835 A JPH02288835 A JP H02288835A
- Authority
- JP
- Japan
- Prior art keywords
- poultry
- formalin
- treated
- agent
- sporozoites
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 62
- 210000003046 sporozoite Anatomy 0.000 claims abstract description 34
- 244000144977 poultry Species 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 210000003555 cloaca Anatomy 0.000 claims abstract description 7
- 208000003495 Coccidiosis Diseases 0.000 claims description 22
- 206010023076 Isosporiasis Diseases 0.000 claims description 22
- 229940124536 anticoccidial agent Drugs 0.000 claims description 9
- 239000003224 coccidiostatic agent Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 241000224483 Coccidia Species 0.000 claims description 7
- 239000000243 solution Substances 0.000 abstract description 22
- 208000015181 infectious disease Diseases 0.000 abstract description 13
- 210000000436 anus Anatomy 0.000 abstract description 11
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 238000011081 inoculation Methods 0.000 abstract description 5
- 102000004142 Trypsin Human genes 0.000 abstract description 3
- 108090000631 Trypsin Proteins 0.000 abstract description 3
- 210000000941 bile Anatomy 0.000 abstract description 3
- 239000000725 suspension Substances 0.000 abstract description 3
- 239000012588 trypsin Substances 0.000 abstract description 3
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 239000002504 physiological saline solution Substances 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 210000003250 oocyst Anatomy 0.000 description 25
- 241000223924 Eimeria Species 0.000 description 20
- 239000000523 sample Substances 0.000 description 17
- 241000287828 Gallus gallus Species 0.000 description 16
- 235000013330 chicken meat Nutrition 0.000 description 14
- 235000013594 poultry meat Nutrition 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 12
- 239000013068 control sample Substances 0.000 description 10
- 230000003902 lesion Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 208000032843 Hemorrhage Diseases 0.000 description 6
- 230000000740 bleeding effect Effects 0.000 description 6
- 241000286209 Phasianidae Species 0.000 description 5
- 210000003608 fece Anatomy 0.000 description 5
- 229960005486 vaccine Drugs 0.000 description 5
- 241000223932 Eimeria tenella Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 101100492811 Drosophila melanogaster tefu gene Proteins 0.000 description 3
- 241000499563 Eimeria necatrix Species 0.000 description 3
- 241001441730 Triacanthidae Species 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 230000003903 intestinal lesions Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000499566 Eimeria brunetti Species 0.000 description 2
- 241000223934 Eimeria maxima Species 0.000 description 2
- 241000272458 Numididae Species 0.000 description 2
- 208000027503 bloody stool Diseases 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 241000321096 Adenoides Species 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000223931 Eimeria acervulina Species 0.000 description 1
- 241000289819 Eimeria adenoeides Species 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000002534 adenoid Anatomy 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10287690A JPH02288835A (ja) | 1990-04-20 | 1990-04-20 | 抗コクシジウム剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10287690A JPH02288835A (ja) | 1990-04-20 | 1990-04-20 | 抗コクシジウム剤 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4607281A Division JPS57159719A (en) | 1981-03-27 | 1981-03-27 | Coccidiostatic |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02288835A true JPH02288835A (ja) | 1990-11-28 |
| JPH0343253B2 JPH0343253B2 (enExample) | 1991-07-01 |
Family
ID=14339097
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10287690A Granted JPH02288835A (ja) | 1990-04-20 | 1990-04-20 | 抗コクシジウム剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH02288835A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433531B (zh) | 2007-11-13 | 2011-06-22 | 关中田 | 物质甲醛在制备动物球虫病药品中的用途 |
-
1990
- 1990-04-20 JP JP10287690A patent/JPH02288835A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101433531B (zh) | 2007-11-13 | 2011-06-22 | 关中田 | 物质甲醛在制备动物球虫病药品中的用途 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0343253B2 (enExample) | 1991-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0047662B1 (en) | Coccidiosis vaccines | |
| US5055292A (en) | Vaccines for coccidiosis comprising live sporulated oocysts from strains of eimeria species | |
| Williams | Quantification of the crowding effect during infections with the seven Eimeria species of the domesticated fowl: its importance for experimental designs and the production of oocyst stocks | |
| Neitz | Aureomycin in Thieileria parva Infection | |
| DE69520509T2 (de) | In ovo impfung gegen coccidiose | |
| JPS6354692B2 (enExample) | ||
| Rose | Immunity to coccidiosis: protective effect of transferred serum in Eimeria maxima infections | |
| JP3129441B2 (ja) | トリ・コクシジウムに対する継代細胞系およびワクチン | |
| PL184024B1 (pl) | Sposób szczepienia przeciwko kokcydiozie | |
| Brunsdon | Seasonal changes in the level and composition of nematode worm burdens in young sheep | |
| GORE et al. | The biology and pathogenicity of a recent field isolate of Eimeria praecox Johnson, 1930 | |
| McHardy et al. | Treatment of Theileria annulata infection in calves with parvaquone | |
| JPH02288835A (ja) | 抗コクシジウム剤 | |
| HUFF et al. | Cellular aspects of the resistance of chickens to Eimeria tenella infections | |
| JPH0314004B2 (enExample) | ||
| Dwinger et al. | Interference in the establishment of tsetsetransmitted Trypanosoma congolense, T. brucei or T. vivax superinfections in goats already infected with T. congolense or T. vivax | |
| Perry et al. | The extraintestinal stages of Eimeria tenella and E. maxima in the chicken | |
| Stockdale et al. | Resistance to Eimeria zuernii produced after chemotherapy of experimental infection in calves | |
| Borgsteede et al. | The residual effect of treatment with ivermectin after experimental reinfection with nematodes in calves | |
| Mostofa et al. | Effect of an antimuscarinic drug on the plasma pepsinogen activity of sheep infected with Ostertagia circumcincta | |
| Cranfield et al. | Listeriosis in Angolan giraffes | |
| Swales | Controlling Caecal Coccidiosis in Chicks | |
| Thomas et al. | Efficacy of oxfendazole against Nematodims battus and inhibited stages of sheep nematodes | |
| Biryukov et al. | The Effects of Vaccination on the Subsequent Sensibility of Eimerias to Coccidiostatics | |
| Bansal et al. | Efficacy of parvaquone and long-acting oxytetracycline in Theileria annulata infection |